Bengaluru: Karnataka has seen a substantial increase in Covid-19 recovery rate by 5.67% in the last week. Medical Education Minister Dr.K.Sudhakar has tweeted. Everyday there is increase in recovery rate which is higher by 9.17% in Bengaluru city. Overall recovery rate of the state by Sunday evening was 42.81 % and it is 35.14% in Bengaluru, the Minister said in his tweet.
Minister responds to women
Minister Sudhakar has responded to a woman who was struggling to get the dead body of her father in St. Johns hospital Madivala. The hospital was charging money to hand over the body and the minister has directed the officials to resolve the issue. It is an inhuman on part of hospital to refuse handover of the body. I came to know about this incident in the media and responded immediately to help out the women, Dr.Sudhakar said in his tweet.
Dr.Ashu shah a senior consultant & Director of Asian Health care
Dr.Ashu shah is working diligently to protect Cancer patients and senior citizens from deadly COVID-19 virus and Cancer / oncology treatments to reduce the burden on hospitals.She is Supporting poor economic senior citizens.She has more than 500 plus Doctors support for night Emergencies Who are serving to all communities , needy and vulnerable section of society. on ways to reduce the unnecessary crowd in the already overwhelmed hospital.
Dr.Ashu shah said Covid virus is one of the greatest challenges faces between medical & scientific advancements for all of us since the start of this pandemic it has really hit all of us hard. Being a Doctor me my team havn’t stopped their treatment Since covid started we are so proud we saved / touched thousands of lives, And “She said cancer patients should not discontinue or stop the treatment, they should strictly focus more on treatment, they should not panic by taking treatments otherwise disease may get worsen and aggressive.” On an average Cancer patients who are currently going through the treatment gets steriods (Dexona ) before the chemo, are not more susceptible to the covid virus, they might likely to get complications because of their underlying Health condition. Pallative & terminally sick people who are prone, they are likely to get affected on virus because of agrressive nature of disease. To avoid the risk of covid infection cancer patients & thier families should strictly follow all measures advised by WHO Hand wash, hygiene, Mask anf physical distancing, Also should take double precautions not to venture outside their house unnecessarily .
Sobita Rani a Lung cancer survivor Asian health care said, I am lung survivor. Lets not stigmatize any diseases, I was a cancer patient doesnt mean that its end of life she also said Thinking how tough days went with great support of Dr. Ashu shah she is an angel and saviour to many. Having cancer is not the end of life. I’m a warrior of Lung cancer a victor & I feel myself very fortunate as they have sponsored my oncology treatment free of cost. she was my ray of sunshine when I was lost in the darkness. May God give you strength and blessings to help warriors of life like us. We should break the taboo dont stigmatize any diseases i want to say everyone as a victor iam proud to say that i am stronger than earlier. Let’s celebrate world lung cancer day together, stay strong and stay safe, An appeal from Sobita Rani.
Dr. Ashu Shah apeal people not to stigmatize covid virus disease (Cancer, T.B patients were stigmatized in the early stages of the disease) rather provide moral support to patients, Break the stigma and taboos as it is no more a deadly disease. and such patients should be treated equally.
● ‘NO’ Vertical transmission of COVID-19 through breastfeeding
● Breastfeeding rates in Karnataka for infants under the age of 6 months have shown a fall of 5% in the last decade; 47% of infants are not being breastfed exclusively
● It has become essential to focus on promoting breastfeeding practices and spreading awareness around the subject in families and in public.
● Providing alternate options through milk banks such as Amaara can be beneficial for those children whose mothers cannot breastfeed them due to various reasons.
Bangalore, 1st August 2020: Fortis La Femme Hospital, Richmond road today along with Breast Milk Foundation supports World Breastfeeding Week through its pioneering initiative, ‘Amaara’ the first Pasteurized Human Milk Bank in Bengaluru,Karnataka launched 34 months ago in collaboration with the Breast Milk Foundation. The objective of Amaara is to provide all premature and critically-ill babies with human breast milk. Through this initiative, an opportunity is provided to all qualified donors across Karnataka to donate their milk.
According to WHO at present, data are not sufficient to conclude vertical transmission of COVID-19 through breastfeeding. In infants, the risk of COVID-19 infection is low, the infection is typically mild or asymptomatic, while the consequences of not breastfeeding and separation between mother and child can be significant. At this point it appears that COVID-19 in infants and children represents a much lower threat to survival and health than other infections that breastfeeding is protective against. The benefits of breastfeeding and nurturing mother-infant interaction to prevent infection and promote health and development are especially important when health and other community services are themselves disrupted or limited. Adherence to infection prevention and control measures is essential to prevent contact transmission between COVID-19 suspected or confirmed mothers and their newborns and young infants. Based on available evidence, WHO recommendations on the initiation and continued breastfeeding of infants and young children also apply to mothers with suspected or confirmed COVID-19.
In the past decade, Karnataka has witnessed a 5% fall in infants under the age of 6 months who are exclusively breastfed. As per the data available, National Family Health Survey reports that 54.2% infants younger than 6 months are breastfed exclusively, which was 58.6% in 2005-06. The overall record in India is 55% on the same parameters, with a large ground left to cover in the direction. Promoting healthy breastfeeding practices comes across as of paramount importance to encourage family member and mothers to support breastfeeding in families.
Mr Srikant Subudhi, Facility Director and Unit Head, Fortis La Femme Hospital said; “As a healthcare company based on women’s health, much of our effort is to promote breastfeeding. While in India the breastfeeding initiation rate is 41.5%, according to UNICEF; at Fortis La Femme the average rate for the last quarter is around 80% for all our 4 units. In fact, at Bangalore unit we have the breastfeeding rate past 89%. While the government is progressing towards designing policies and making efforts to facilitate breast feeding, we as an organization also leave no stone unturned to ensure this healthy practice for all our patients with trained and certified Lactation counsellors available to provide guidance and support. For our external patients, we have information sharing groups, a Breast feeding support line and appointments available with our experts through the journey. Breastfeeding is the first benchmark of motherhood and we believe in educating and supporting women on it from all possible directions. We have even got a Breast Milk Bank at two of our hospitals to stretch our support to premature infants who need the nourishment of Breast milk but May have to rely on donor milk for the initial period. All babies have a right to Mother’s milk and we at La Femme ensure to make it happen!”
Dr Sreenath Manikanti, HOD Neonatology, Fortis La Femme Hospital,who also Heads Amaara Human Milk Bank said :Breast feeding is complete nutrition to the infant and a convenient method of feeding the infant with many added advantages. Apart from containing all the nutrients that a baby needs, it is easily digestible and is assimilated by the body, protects baby from infections as antibodies from the mother protects the infant who is breastfed, is an economical and a natural way to promote mother baby bonding, prevents allergic reaction and subsequent development of lifestyle diseases during adulthood such as diabetes &coronary heart disease. Breastfeeding helps the baby’s physical and intellectual development, protects mother’s health by helping early involution of the uterus, reduces post partum bleeding, so prevents anemia, reduces the risk of breast and ovarian cancer, and helps delay the birth of the second child.
By Dr Niti Raizada Senior Consultant, Medical Oncologist and Hemato-Oncologist, Vikram Hospital, Bengaluru
Bengaluru, July 31,2020 : Lung cancer is the most commonly diagnosed cancer across the world (11.6% of the total cases) across both males and females, and the leading cause of cancer-related deaths (18.4% of the total cancer deaths). Its incidence and mortality is rapidly growing worldwide. The reasons are complex but reflect both aging and growth of the population.
Small cell lung cancer occurs in 20% of all lung cancer cases. Its treatment is focussed on chemotherapy with or without radiation therapy. For non-small-cell lung cancer, which is the most common type of lung cancer, chemotherapy, immunotherapy and oral biologic therapies are given.
The Covid-19 pandemic is one of the greatest challenges that modern medicine has ever faced. Amongst all the panic generated by Covid, one should not lose sight of the fact that lung cancer is a deadly disease and its treatment cannot wait despite the pandemic because of the aggressive nature of the disease.
Lung cancer patients are not more susceptible to the Covid virus compared to other people. However, if they get infected, they are more likely to get complications because of their underlying health condition.
To avoid the risk of Covid infection, lung cancer patients and their families should strictly follow all measures advised for the general public. Social distancing, hygiene and face masks are universal precautions that should be taken by them.
The treatment of lung cancer has seen pathbreaking research in the past decade, with several new molecularly targeted therapies and immunotherapy now available. Molecular targeted therapies which are based on newer diagnostic modalities like NGS (next generation sequencing) are increasingly used in lung cancer now. These are much safer and do not require frequent medical monitoring. In the last few months, the US FDA has approved several new oral targeted drugs for lung cancer. In India, these may also be available soon.
based on Bengaluru based Scientist Dr. Rajah Vijay Kumar’s invention
A powerful but small device that attacks and disables Coronavirus from infecting people under the Brand name Forbes CORONAGUARD (Powered by SHYCOCAN)
Covid19 continues to spread rapidly in India and across the world. At the last count over 16 million people have been infected with the deadly virus globally and 50,000 new cases have emerged in India in the last 24 hours. Besides the loss of lives, this epidemic has been a crushing blow to the economy, pushing people into joblessness and poverty. But now an invention from a scientist in Bengaluru, India Dr. Rajah Vijay Kumar promises to change all that. And fast. Dr. Rajah Vijay Kumar has invented the Scalene Hypercharge Corona Canon (SHYCOCAN) a powerful device that attacks and disables Coronavirus, SHYCOCAN is CE marked (EU- Class I) and has been cleared by US FDA under ‘Enforcement Policy for Sterilizers, Disinfectant Devices and Air Purifiers during the COVID 19 Public Health Emergency’. This device will be manufactured and marketed in India by Eureka Forbes under the brand name FORBES CORONAGUARD (Powered by SHYCOCAN).
While the pandemic continues to rage globally, plans revolving primarily around social distancing and personal hygiene are afoot thus raising wide-spread concern with respect to the reopening of schools, places of worship and restaurants among other workplaces. In lieu of this, FORBES CORONAGUARD aims to provide real time protection against infection from coronavirus in closed spaces. This is a revolutionary virulence prevention device which promises to neutralize and disable 99.9% of coronavirus in the air surfaces, within closed indoor spaces.
In order to understand how FORBES CORONAGUARD works, one needs to understand how the COVID 19 Virus spreads. Coronavirus spreads between people who are in close contact with one another. Droplets that are produced when an infected person talks, coughs or sneezes may infect a normal person by possible inhalation into their lungs. The attachment of the SARS-CoV-2 to the host cell receptor is caused by the spike protein (S-protein). The Spike Protein seeks the host cell receptors thereby infecting people by multiplying thereafter.
Announcing it to the media, Marzin R. Shroff, CEO & Managing Director Eureka Forbes said, “For over 38 years, we at Eureka Forbes have been protecting Indians against harmful viruses and bacteria in water, air and surfaces. We are privileged to be working together with Dr. Rajah Vijay Kumar in bringing Forbes Coronaguard to India. It is a device that offers real time protection against infection from the Coronavirus within closed spaces. Our vision is to contain the spread of this disease and to make a positive difference to the lives of millions of Indians first, and then to the rest of the world.”
“An important feature of this technology is that only the Corona family of viruses is targeted, while bacteria, fungi or other eco-friendly micro-organisms are not, allowing for 24/7, safe deployment,” quoted Dr. Rajah Vijay Kumar.
“We intend on prioritising deployment of the CORONAGUARD in all high-risk and essential service environments first. This will help create ‘safer zones’ in homes, health care facilities, grocery and essential stores, restaurants & hotels, schools, colleges, places of worship, residential, corporate, industrial and sporting environments among others according to Mr Shroff. He added, it is a very practical and complimentary solution – along with the use of personal protective equipment (PPE), where necessary – to reduce burdens of indefinite social distancing”.
“While we go through the final ratifications and necessary approvals, the commercial production of CoronaGuard is expected by August end/early September 2020. We are looking at a launch and pre-bookings that should open in Mid-August” said Mr. Shroff.
Initiatives surrounding the R&D on the device prototype began in April 2019, to stem the decline in work force productivity due to the common cold and seasonal Influenza in Scalene’s facilities. Over the last 6 months, Dr. Rajah Vijay Kumar and his team have worked tirelessly, and successfully completed extensive EU-CE – mandated safety testing undertaken by the Underwriters Laboratories (UL). Scalene has since obtained the CE Mark with Class I designation, enabling the expedited manufacture, distribution, and sales in all CE-compliant countries/markets, including India. US FDA ‘Enforcement Policy for Sterilizers, Disinfectant Devices, and Air Purifiers During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency approved it together with multiple certifications from prestigious international laboratories, it is proven to be safe for infants, pregnant mothers and others with no side effects and/or interference with other electronic devices.
Salient features:
– Conceptualised and made in India
– Attacks, detects, disablesand protects against 99.9% Corona
– Chemical free, odour free, stain free and no side effects
City Today News 
You must be logged in to post a comment.